Radiation sensitivity of megakaryocyte colony-forming cells in human placental and umbilical cord blood

Radiation Research

Volumn 153, Issue 2, 2000, Pages 144-152

  Kashiwakura, Ikuo ^a   Kuwabara, Mikinori ^b   Inanami, Osamu ^b   Murakami, Miho ^a   Hayase, Yukitoshi ^a   Takahashi, Tsuneo A ^c   Takagi, Yoshinari ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; FLT3 LIGAND; FLUORESCEIN ISOTHIOCYANATE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 3; RECOMBINANT THROMBOPOIETIN;

ARTICLE; CELL ISOLATION; CELL MATURATION; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; COLONY FORMATION; COLONY FORMING CELL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MEGAKARYOCYTE; PLACENTA; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; UMBILICAL CORD BLOOD; X IRRADIATION;

EID: 0033967261     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0144:RSOMCF]2.0.CO;2     Document Type: Article

References (46)

1. G. Grilli, E. Nothdurft and T. M. Fliedner, Radiation sensitivity of human erythropoietic and granulopoietic progenitor cells in the blood and in the bone marrow. Int. J. Radiat Biol. 41, 685-687 (1982).
2. F. M. Uckun and C. W. Song, Radiobiological features of human pluripotent bone marrow progenitor cells (CFU-GEMM). Int. J. Radiat. Oncol. Biol. Phys. 17, 1021-1025 (1989).
3. D. W. van Bekkum, Radiation sensitivity of the hematopoietic stem cell. Radiat. Res. 128 (Suppl.), S4-S8 (1991).
4. M. C. Baird, J. H. Hendry, M. T. Dexter and N. G. Testa, The radio-sensitivity of populations of murine hematopoietic colony-forming cells that respond to combinations of growth factors. Exp. Hematol. 19, 282-287 (1991).
5. + hematopoietic progenitors from human umbilical cord blood. Exp. Hematol. 21, 1436-1441 (1993).
6. + hematopoietic progenitor cells. Radiat. Res. 147, 61-69 (1997).
7. B. L. Ziegler, P. S. Sandor, U. Plappert, S. Thoma, R. Muller, T. Bock, C. A. Thomas, W. Nothdurft and T. M. Fliedner, Short-term effects of early-acting and multilineagc hematopoietic growth factors on the repair and proliferation of irradiated pure cord blood (CB) CD34 hematopoietic progenitor cells. Int. J. Radiat. Oncol. Biol. Phys. 40, 1193-1203 (1998).
8. Z. C. Han, S. Bellucci and J. P. Caen, Megakaryocytopoiesis: Characterization and regulation in normal and pathologic states. Int. J. Hematol. 54, 3-14 (1991).
9. E. M. Mazur, Historical perspective and overview. In Thrombopoiesis and Thrombopoietins (D. J. Kuter, P Hunt, W. Sheridan and D. Zucker-Franklin, Eds.), pp. 95-108. Humana Press, Totawa, NJ, 1997.
10. F. J. de Sauvage, P. E. Hass, S. D. Spencer, B. E. Malloy, A. L. Gurney, S. A. Spencer, W. C. Darbonne, W. J. Henzel, S. C. Wong and D. L. Eaton, Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369, 533-538 (1994).
11. S. Lok, K. Kaushansky, R. D. Holly, J. L. Kuijper, C. E. Lofton-Day, P. J. Oort, F. J. Grant, M. D. Heipel, S. K. Burkhead and D. C. Forster, Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369, 565-568 (1994).
12. T. D. Bartley, J. Bogenberger, R Hunt, Y-S. Li, H. S. Lu, F. Martin, M-S. Chang, B. Samal, J. L. Nichol and R. A. Bosselman, Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77, 1117-1124 (1994).
13. E C. Zeigler, F. de Sauvage, H. R. Widmer, G. A. Keller, C. Donahue, R. D. Schreiber, B. Malloy, P. Hass, D. Eaton and W. Matthews, In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84, 4045-4052 (1994).
14. V. C. Broudy, N. L. Lin and K. Kaushansky, Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85, 1719-1726 (1995).
15. N. Debili, E. Cramer, E Wendling and W. Vainchenker, In vitro effects of Mpl ligand on human hematopoietic progenitor cells. In Thrombopoiesis and Thrombopoietins (D. J. Kuter, P. Hunt, W. Sheridan and D. Zucker-Franklin, Eds.), pp. 217-235. Humana Press, Totawa, NJ, 1997.
16. Y. Takagi, M. Shikita, T. Terasima and S. Akaboshi, Specificity of radioprotectivc and cytotoxic effects of cysteamine in HeLa S3 cells: Generation of peroxide as the mechanism of paradoxical toxicity. Radiat. Res. 60, 292-301 (1974).
17. I. Kashiwakura, M. Murakami, Y. Hayase and Y. Takagi, Effect of a hematopoietic promoting factor derived from porcine kidney on the proliferation of mouse hematopoietic progenitor cells in liquid culture. Biol. Pharmacol. Bull. 18, 1476-1481 (1995).
18. T. A. Takahashi, K. Shibata, I. Kashiwakura, Y. Hayase, Y. Takagi and S. Sekiguchi, The effect of a hematopoietic-promoting factor (HPF) extracted from porcine kidney on the proliferation of human hematopoietic progenitor cells. Res. Commun. Mol. Pathol. Pharmacol. 91, 185-193 (1996).
19. S. Siena, M. Bregni, L. Bonsi, I. Sklenar, G. P. Bagnara, G. Bonadonna and A. M. Gianni, Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. Exp. Hematol. 21, 1583-1590 (1993).
20. T. Hagiwara, I. Kodama, K. Horie, T. Kato and H. Miyazaki, Proliferativc properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin. Exp. Hematol. 26, 228-235 (1998).
21. E. Yuen, R. D. Brown, H. Kroncnberg and K. A. Rickard, Human bone marrow progenitor cells stimulated by cord blood. Exp. Hematol. 14, 771-775 (1986).
22. C. E. Carow, G. Hangoc and H. E. Broxmeyer, Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: An effect enhanced by cord blood plasma. Blood 81, 942-949 (1993).
23. B. Meister, M. Herold, A. Mayr, M. Widschwendter, H. Maurer, K. Heim and W. Sperl, Interleukin-3, interleukin-6, granulocyte-macrophage colony-stimulating factor and erythropoietin cord blood levels of preterm and term neonates. Eur. J. Pediatr. 152, 569-573 (1993).
24. P. J. Simmons and B. Torok-Storb, CD34 expression by stromal precursors in normal human adult bone marrow. Blood 78, 2848-2853 (1991).
25. P. J. Simmons and B. Torok-Storb, Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78, 55-62 (1991).
26. B. Torok-Storb, Cellular interactions. Blood 72, 373-385 (1988).
27. H. E. Broxmeyer, G. W. Douglas, G. Hangoc, S. Cooper, J. Bard, D. English. M. Arny, L. Thomas and E. A. Boyse, Human umbilical cord blood as a potential source of transplantable hematopoietic stem/ progenitor cells. Proc. Natl. Acad. Sci. USA 86, 3828-3832 (1989).
28. H. Nishihira and Y. Toyoda, Studies on hematopoietic stem cells of newborn peripheral blood and cord blood correlation between number of stem cells and gestational ages. Nihon Shouni Ketsuekigaku Zasshi 7, 558-563 (1993).
29. H. Nishihira, K. Honda, Y. Toyoda, H. Gotoh, A. Iguchi, K. Tabuchi, H. Kigasawa and T. Nagao, Studies on umbilical cord blood transplantation - total number of collectable hematopoietic stem cells from umbilical cord of placentae. Nihon Shouni Ketsuekigaku Zasshi 9, 13-17 (1995).
30. - cells in cord blood and bone marrow. Blood 86, 3745-3753 (1995).
31. G. Zauli, L. Valvassori and S. Capitani, Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. Blood 81, 385-390 (1993).
32. V. R. Deutsch, T. A. Olson, A. Nagler, S. Slavin, R. F. Levine and A. Eldor, The response of cord blood megakaryocyte progenitors to IL-3, IL-6 and aplastic canine serum varies with gestational age. Br. J. Haematol. 89, 8-16 (1995).
33. J. Tong, M. S. Gordon, E. F. Srour, R. J. Cooper, A. Orazi, I. McNiece and R. Hoffman, In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 82, 784-791 (1993).
34. P. Lefebvre, J. N. Winter, L. E. Kahn, J. G. Giri and I. Cohen, Megakaryocyte ex vivo expansion potential of three hematopoietic sources in serum and serum-free medium. J. Hematother. 8, 199-208 (1999).
35. X. X. Du, C. M. Doerschuk, A. Orazi and D. A. Williams, A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83, 33-37 (1994).
36. J. P. Leonard, C. M. Quinto, M. K. Kozitza, T. Y. Neben and S. J. Goldman, Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 83, 1499-1506 (1994).
37. S. Hudak, M. W. Leach, Y. Xu, S. Menon and D. Rennick, Radio-protective effects of flk2/flt3 ligand. Exp. Hematol. 26, 515-522 (1998).
38. A. Gratwohl, L. John, H. Baldomero, J. Roth, A. Tichelli, C. Nissen, S. D. Lyman and A. Wodnar-Filipowicz, FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. Blood 92, 765-769 (1998).
39. M. O. Muench, M. G. Roncarolo, S. Menon, Y. Xu, R. Kastelein, S. Zurawski, C. H. Hannum, J. Culpepper, F Lee and R. Namikawa, FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85, 963-972 (1995).
40. - bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood 90, 2282-2292 (1997).
41. S. Ebbe and E. Phalen, Does autoregulation of megakaryocytopoiesis occur? Blood Cells 5, 123-138 (1979).
42. H. M. Lazarus and J. M. Rowe, Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation. Blood Rev. 8, 169-178 (1994).
43. E. J. Shpall, C. F. LeMaistre, K. Holland, E. Ball, R. B. Jones, R. Saral, C. Jacobs, S. Heimfeld, R. Berenson and R. Champlin, A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 90, 4313-4320 (1997).
44. M. S. Gordon, Thrombopoietic activity of recombinant human interleukin 11 in cancer patients receiving chemotherapy. Cancer Chemother. Pharmacol. 38 (Suppl.), S96-S98 (1996).
45. S. Vadhan-Raj, Recombinant human thrombopoietin: Clinical experience and in vivo biology. Semin. Hematol. 35, 261-268 (1998).
46. K. Kaushansky, The thrombocytopenia of cancer. Prospects for effective cytokine therapy. Hematol. Oncol. Clin. North Am. 10, 431-455 (1996).